Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antisense oligonucleotides and their use for treating Pendred syndrome

Antisense oligonucleotides and their use for treating Pendred syndrome

US Patent 11312959 · Granted Apr 26, 2022

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Vehicle-mounted light detection and ranging (LIDAR) system2020
Optical comb filter having first, second and third GT resonant cavities2019
Flat-top tunable filter2018
Protein chromatography matrices with hydrophilic copolymer coatings2017
Compositions and methods for modulation of SMN2 splicing in a subject2017
Laser desorption ionization mass spectrometry using a particulate separation bed2017
Compounds and methods for modulating interaction between proteins and target nuc2016
Compositions and methods for modulation of SMN2 splicing in a subject2015
Compositions and methods for modulation of SMN2 splicing2015
Characterizing a frequency channel in an optical network2014
Compositions and methods for modulation of SMN2 splicing2013
Optical device for rearranging wavelength channels2012